BlackRock »

Eagle Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.7M 898k 5.24
2023-09-30 $14M 889k 15.77
2023-06-30 $20M 1.0M 19.44
2023-03-31 $53M 1.9M 28.37
2022-12-31 $55M 1.9M 29.23
2022-06-30 $86M 1.9M 44.44
2021-06-30 $89M 2.1M 42.82
2021-03-31 $83M 2.0M 41.73
2020-12-31 $90M 1.9M 46.53
2020-09-30 $81M 1.9M 42.45
2020-03-31 $77M 1.7M 45.95
2019-12-31 $109M 1.8M 60.00
2019-09-30 $98M 1.7M 56.54
2019-06-30 $97M 1.7M 55.69
2019-03-31 $84M 1.7M 50.47
2018-12-31 $70M 1.7M 40.29
2018-09-30 $121M 1.7M 69.33
2018-06-30 $108M 1.4M 75.71
2018-03-31 $66M 1.2M 52.75
2017-09-30 $74M 1.3M 58.71
2016-12-31 $52k 656 79.57
2016-09-30 $54k 776 70.09
2016-06-30 $29k 721 39.62
2016-03-31 $21k 503 41.67
2015-12-31 $17k 191 89.01
2015-09-30 $14k 191 73.30
2015-06-30 $183k 2.3k 80.86